Related Experiment Video

Updated: Jul 11, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

New molecularly targeted therapies for lung cancer

Sophie Sun1, Joan H Schiller, Monica Spinola

  • 1Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

The Journal of Clinical Investigation
|October 3, 2007
PubMed

Insights

Lung cancer causes many deaths globally and is hard to detect early. New molecularly targeted therapies offer hope for improved early detection, prevention, and treatment, potentially improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Clinical Medicine

Background:

  • Lung cancer is the leading cause of cancer-related mortality worldwide.
  • Late-stage diagnosis and limited treatment efficacy contribute to poor prognoses.
  • Understanding molecular pathogenesis is crucial for advancing lung cancer care.

Purpose of the Study:

  • To review recent advances in lung cancer detection, prevention, and treatment.
  • To highlight the clinical implications of novel molecular insights.
  • To focus on emerging molecularly targeted therapies.

Main Methods:

  • Review of current literature on lung cancer molecular pathogenesis.
  • Analysis of recent clinical trial data for targeted therapies.
  • Synthesis of information on early detection and prevention strategies.

Main Results:

  • Significant progress has been made in understanding lung cancer biology.
  • Development of rationally designed early detection and prevention methods.
  • Numerous molecularly targeted therapies are in various stages of development.

Conclusions:

  • Advances in molecular understanding are transforming lung cancer management.
  • Targeted therapies represent a promising frontier for improving patient survival.
  • Continued research is essential for optimizing lung cancer treatment strategies.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.